Who is moving to which position
Resolved 12 June 2026Incoming appointee
1 itemIn addition to confirming that Miyata Masahiko (宮田昌彦)'s health has recovered and that there are no impediments to his performing his duties as a Representative Director, the Company determined that it would be beneficial to leverage his extensive experience, knowledge and external credibility, which he has developed through leading the management of the Company Group, as well as his broad network in the medical device industry, to support future sustainable growth and further strengthen the management structure.
| Item | Details |
|---|---|
| Resolution date | 12 June 2026 |
| Scheduled Appointment Date | 1 July 2026 |
| Name of appointee | Miyata Masahiko (宮田 昌彦) |
| Appointee's new position | Representative director and chairman |
| Appointee's previous position | Chairman of the Board |
| Appointee's date of birth | 15 March 1967 |
| Year the appointee joined the Company | 1994 |
| Number of shares held by the appointee | 5,822,500 shares (record date: Not disclosed) |
| Reason for change | In addition to confirming that Miyata Masahiko (宮田昌彦)'s health has recovered and that there are no impediments to his performing his duties as a Representative Director, the Company determined that it would be beneficial to leverage his extensive experience, knowledge and external credibility, which he has developed through leading the management of the Company Group, as well as his broad network in the medical device industry, to support future sustainable growth and further strengthen the management structure. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to confirming that Miyata Masahiko (宮田昌彦)'s health has recovered and that there are no impediments to his performing his duties as a Representative Director, the Company determined that it would be beneficial to leverage his extensive experience and knowledge, external credibility, and broad network in the medical device industry to support future sustainable growth and further strengthen the management structure.